| High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles R Kuai, D Li, YE Chen, JJ Moon, A Schwendeman ACS Nano 10, 3015-41, 2016 | 345 | 2016 |
| High-density lipoprotein-mimicking nanodiscs for chemo-immunotherapy against glioblastoma multiforme P Kadiyala, D Li, FM Nuñez, D Altshuler, R Doherty, R Kuai, M Yu, ... ACS nano 13 (2), 1365-1384, 2019 | 215 | 2019 |
| Predicting drug release kinetics from nanocarriers inside dialysis bags M Yu, W Yuan, D Li, A Schwendeman, SP Schwendeman Journal of Controlled Release 315, 23-30, 2019 | 157 | 2019 |
| Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice P Kadiyala, SV Carney, JC Gauss, MB Garcia-Fabiani, S Haase, ... The Journal of clinical investigation 131 (4), 2021 | 104 | 2021 |
| The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation. K Yu, W Zhang, L Limin, P Song, D Li, R Du, W Ren, W Huang, Dan, Lu, ... Int J Nanomedicine 8, 2473-85, 2013 | 78 | 2013 |
| Antitumor activity of dichloroacetate on C6 glioma cell: in vitro and in vivo evaluation. Y Duan, X Zhao, W Ren, X Wang, K Yu, D Li, X Zhang, Q Zhang Onco Targets Ther 6, 189-98, 2013 | 67 | 2013 |
| Antitumor efficacy of a novel CLA-PTX microemulsion against brain tumors: in vitro and in vivo findings. D Li, Y Ke, L Jiesi, X Ke, Y Duan, R Du, P Song, K Yu, W Ren, D Huang, ... Int J Nanomedicine 7, 6105-14, 2012 | 37 | 2012 |
| Synthetic HDL nanoparticles delivering docetaxel and CpG for chemoimmunotherapy of colon adenocarcinoma LM Scheetz, M Yu, D Li, MG Castro, JJ Moon, A Schwendeman International journal of molecular sciences 21 (5), 1777, 2020 | 33 | 2020 |
| Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization J Tang, D Li, L Drake, W Yuan, S Deshaine, EE Morin, R Ackermann, ... J Lipid Res 58, 124-136, 2016 | 29 | 2016 |
| Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation Y Luo, Y Guo, H Wang, M Yu, K Hong, D Li, R Li, B Wen, D Hu, L Chang, ... EBioMedicine 74, 2021 | 27 | 2021 |
| Effect of synthetic high density lipoproteins modification with polyethylene glycol on pharmacokinetics and pharmacodynamics D Li, MV Fawaz, EE Morin, R Ming, D Sviridov, J Tang, R Ackermann, ... Molecular pharmaceutics 15 (1), 83-96, 2018 | 27 | 2018 |
| Apolipoprotein Mimetic Peptides for Stimulating Cholesterol Efflux D Li, S Gordon, A Schwendeman, TA Remaley Apolipoprotein Mimetics in the Management of Human Disease, 29-42, 2015 | 26 | 2015 |
| Phospholipid component defines pharmacokinetic and pharmacodynamic properties of synthetic high-density lipoproteins MV Fawaz, SY Kim, D Li, R Ming, Z Xia, K Olsen, ID Pogozheva, ... Journal of Pharmacology and Experimental Therapeutics 372 (2), 193-204, 2020 | 21 | 2020 |
| Pharmacokinetics and safety of single-dose tedizolid phosphate in children 2 to< 12 years of age AC Arrieta, JY Ang, C Espinosa, O Fofanov, C Tøndel, MZ Chou, ... The Pediatric Infectious Disease Journal 40 (4), 317-323, 2021 | 11 | 2021 |
| Does ligand-receptor mediated competitive effect or penetrating effect of iRGD peptide when co-administration with iRGD-modified SSL? W Zhang, K Yu, T Zhong, L Luo, R Du, W Ren, D Huang, P Song, D Li, ... J Drug Target 23, 897-909, 2015 | 11 | 2015 |
| Systematic evaluation of the effect of different apolipoprotein AI mimetic peptides on the performance of synthetic high-density lipoproteins in vitro and in vivo W Yuan, K Ernst, R Kuai, EE Morin, M Yu, DO Sviridov, J Tang, L Mei, D Li, ... Nanomedicine: Nanotechnology, Biology and Medicine 48, 102646, 2023 | 9 | 2023 |
| Compositions and methods for disease treatment using nanoparticle delivered compounds A Schwendeman, M Cohen, C Subramanian, D Kuai, Rui, Li, P White, ... | 9* | 2017 |
| Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease EK Bajwa, D Cislak, A Kumar, D Li, EJ Messina, T Reynders, JF Denef, ... International Journal of Chronic Obstructive Pulmonary Disease, 1105-1121, 2024 | 3 | 2024 |
| Population pharmacokinetics, exposure-response, and probability of target attainment analyses for tedizolid in adolescent patients with acute bacterial skin and skin structure … D Li, PE Sabato, B Guiastrennec, A Ouerdani, HP Feng, V Duval, ... Antimicrobial Agents and Chemotherapy 65 (12), 10.1128/aac. 00895-21, 2021 | 3 | 2021 |
| Inhibition of 2-Hydroxyglutrate Elicits Metabolic-reprograming and Mutant IDH1 Glioma Immunity P Kadiyala, SV Carney, JC Gauss, MB Garcia-Fabiani, FJ Núñez, ... bioRxiv, 2020.05. 11.086371, 2020 | | 2020 |
